PROTECT YOUR BUSINESS
The World Vaccine Influenza Congress is a scientific and technical focused conference aimed at tackling the commercial challenges associated with building viable and sustainable influenza vaccine portfolios.
The congress is where big pharma, early stage and mid stage biotechs, government and regulatory bodies and service providers collaborate to address influenza policy and planning, influenza research & development, and stakeholder partnerships.
- 2-congress days, 3 plenary session, 30+ speakers
- 25+ sessions and 16hrs of defined content
- 10hrs+ of immersive networking events
Come to World Vaccine Influenza Congress Lyon and learn:
- How governmental requirements, market access and uptake affects your portfolio
- How to adopt regional regulatory procedures and risk management plans
- How to develop corporate growth strategies and R&D pipelines
- How to align seasonal, pandemic and universal influenza research
- How to prepare for seasonal and pandemic vaccine production demand
- How to advance regulatory approval and authorisation / standardisation
Who should attend:
- Pharmaceutical Companies
- Biotechnology Companies
- Government / Regulatory bodies
- Academic/ Research Institutes
- Contract Research Organisations
- Contract Manufacture Organisations
- Equipment Manufacturers
- Technology Platform Providers
- Global Consultants
- Venture Capitalists
What job functions should be attending?
- Executive (CEO, CSO, CMO, COO)
- Drug discovery / development
- Research and Development
- External R&D
- Public / Governmental Affairs
- Scientific / Medical Affairs
- Corporate / Business Development
Who should sponsor?
- Pharmaceutical Companies
- Large Biotechnology Companies
- SME Biotechs
- Contract Research Organisations
- Contract Manufacture Organisations
- Equipment Manufacturers / Technology Providers
- Consultants
